ArticleFrontiers in medicine2026
Brain perivascular diffusion and cognitive impairment in heart failure with preserved ejection fraction.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized as a systemic cardiovascular disorder that may involve extra-cardiac organs, including the brain. This study aimed to investigate whether brain perivascular diffusivity, assessed using diffusion tensor image analysis along the perivascular space (DTI-ALPS), is associated with cognitive performance, assessed with the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE), in patients with HFpEF. Materials and methods: Thirty-five patients with HFpEF and 20 healthy controls underwent brain diffusion kurtosis imaging and neuropsychological assessment. Left, right, and mean DTI-ALPS indices were calculated for each participant. Group differences were evaluated using independent-samples Results: Compared with healthy controls, patients with HFpEF had lower MoCA (22.34 ± 3.38 vs. 28.70 ± 1.69; Conclusion: HFpEF was associated with cognitive impairment and a left-predominant reduction in perivascular diffusivity as reflected by DTI-ALPS. These findings suggest that DTI-ALPS may be a candidate neuroimaging marker of brain involvement in HFpEF. Given the cross-sectional design, causal and predictive interpretations should be avoided until confirmed by longitudinal multimodal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.